Dr. Dave Rabin, a leading medical professional, joins retired army sergeant Jon Lubecky, who participated in MAPS MDMA therapy trials, to discuss the FDA's recent rejection of MDMA-assisted therapy. They delve into the implications of this decision and its impact on veterans seeking help. Unethical behavior from organizations like Symposia, including falsifying information, raises serious ethical concerns. The conversation emphasizes the urgent need for continued advocacy, transparency, and hope for future access to these transformative treatments.